In Vitro and In Vivo Effects of Palmaria palmata Derived Peptides on Glucose Metabolism
Open Access
- 29 March 2021
- journal article
- research article
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 27 (3) , 1667-1676
Abstract
Three synthetic peptides, ILAP, LLAP and MAGVDHI, derived from a Palmaria palmata protein hydrolysate were assessed for their antidiabetic potential in vitro and in vivo. In addition to inhibiting dipeptidyl peptidase-IV in a cell-based in situ assay all three peptides significantly increased the half-life of the incretin hormone glucagon-like peptide-1 (GLP-1). ILAP and LLAP mediated a significant increase (p < 0.001) in insulin secretion from BRIN-BD11 cells compared to the glucose control, while MAGVDHI had no insulinotropic activity at an eqimolar concentration (10–6 M). A significant increase in the concentration of cyclic adenosine monophosphate production in BRIN-BD11 cells mediated by ILAP (p < 0.001) and LLAP (p < 0.01) compared to the basal control, would indicate that insulin secretion may be mediated by membrane based activation. Furthermore, ILAP and LLAP acted as glucose-dependent insulinotropic polypeptide (GIP) secretagogues, stimulating a significant increase (p < 0.01) in the concentration of GIP released from enteroendocrine STC-1 cells compared to the glucose control. When tested in vivo in healthy male NIH Swiss mice, ILAP and LLAP, mediated a significant increase (p < 0.01) in plasma insulin and decrease (p < 0.05) in blood glucose, respectively, compared to the control. MAGVDHI mediated a significant (p < 0.001) sustained reduction in food intake in food deprived trained mice. These results demonstrate that the Palmaria palmata peptides studied herein have prospective antidiabetic activity and have the potential to act as agents that can be used alone or in combination with drugs, to aid in the prevention and management of Type 2 diabetes mellitus.Keywords
Funding Information
- Department of Agriculture, Food and the Marine (13/F/467, 14/F/873)
- Department of Education and Learning, Northern Ireland (PhD Scholarship)
This publication has 27 references indexed in Scilit:
- Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: Differences and similaritiesEuropean Journal of Internal Medicine, 2014
- Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetesProceedings of the Nutrition Society, 2013
- Frog skin peptides (tigerinin-1R, magainin-AM1, -AM2, CPF-AM1, and PGla-AM1) stimulate secretion of glucagon-like peptide 1 (GLP-1) by GLUTag cellsBiochemical and Biophysical Research Communications, 2013
- Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 DiabetesDiabetes Care, 2011
- Amino Acid Metabolism, β-Cell Function, and DiabetesDiabetes, 2006
- Effects of dietary protein on glucose homeostasisCurrent Opinion in Clinical Nutrition and Metabolic Care, 2006
- Glucose-Dependent Insulinotropic Polypeptide Promotes β-(INS-1) Cell Survival via Cyclic Adenosine Monophosphate-Mediated Caspase-3 Inhibition and Regulation of p38 Mitogen-Activated Protein KinaseEndocrinology, 2003
- Gastric Inhibitory Polypeptide Activates MAP Kinase through the Wortmannin-Sensitive and -Insensitive PathwaysBiochemical and Biophysical Research Communications, 1997
- Characterization of a Novel Glucose-Responsive Insulin-Secreting Cell Line, BRIN-BD11, Produced by ElectrofusionDiabetes, 1996
- Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) miceDiabetologia, 1981